US Patent 10071124 Treatment of post-traumatic stress disorder with isolated
Patent 10071124 was granted and assigned to Immodulon Therapeutics Limited on September, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10071124 Treatment of post-traumatic stress disorder with isolated
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.